Orthopedics News: Breaking Orthopedics News, Comments and Articles. - Page: 5

15:39 EST 27th November 2014 | BioPortfolio

Orthopedics News - Page: 5Twitter RSS

Read the latest Orthopedics News from around the world, updated every five minutes. Breaking stories from leading news and press agencies, bloggers and experts on Orthopedics.

Search or Follow Our Orthopedics - Page: 5 News…

If you are looking for more stories, you may wish to search our extensive news archives for relevant stories: Search for More Orthopedics - Page: 5 News.
You can also follow our Orthopedics - Page: 5 news stories on Twitter: @Orthopedics_Bio

Showing "orthopedics musculoskeletal joints ligaments tendons" News Articles 101 to 125 of 1,500+

Monday 17th November 2014

CompPartners Publishes White Paper on Opioid Management

CompPartners has published a white paper, “Opioid Management – a Realistic Approach to Change.” Written by CompPartners’ Medical Director Joyce Ho, MD, the paper calls for more education and involvement of the injured worker. “We need a two-pronged approach, working with the injured worker as well as the treating physician at the onset o...

TissueGene Receives Recommendations from FDA on Pathway to Phase 3 Trial of TG-C for Treatment of Osteoarthritis of the Knee

ROCKVILLE, Md., Nov. 17, 2014 /PRNewswire/ -- TissueGene, Inc., a clinical stage biopharmaceutical company, has received recommendations from the U.S. Food and Drug Administration ("FDA") to submit its Phase 3 protocol for review under the Special Protocol Assessment ("SPA"). These recommendations were in response to TissueGene's request for an end-of-Phase 2 meeting to discuss plans for pivo...

Hip replacement an excellent option for young juvenile arthritis patients

When you think of hip replacement surgery, you generally envision an older adult with painful osteoarthritis. But the procedure is also used for younger patients with juvenile idiopathic arthritis (JIA) whose joints have been severely damaged by the ...

OrthoTrophix Completed Patient Treatments in Part A of the Phase 2 Clinical Trial of a New Cartilage Repair Therapeutic for Knee Osteoarthritis and Initiated Patient Enrollment for Part B

OAKLAND, Calif., Nov. 17, 2014 /PRNewswire/ -- OrthoTrophix, Inc., a privately held biopharmaceutical company, announced today the completion of the dose-finding (Part A) portion of the Phase 2 clinical study of TPX-100 in subjects with osteoarthritis (OA) of the knee. The Company initiated the study in early 2014 (Press Release on February 20, 2014). All 27 subjects in the four dosing cohort...

Spondylitis Global Clinical Trials Review, H2, 2014

Recently added to the BioPortfolio report store, Spondylitis Global Clinical Trials Review, H2, 2014 is a new report from GlobalData published on 2014-10-30. This 60-page report is available in PDF from $2500. Spondylitis Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Spondylitis Global Clinical Trials Review, H2, 2014" provides data on the Spondylitis cli...

PharmaSphere: Emerging Biotechnologies - Stem Cell Therapy

Recently added to the BioPortfolio report store, PharmaSphere: Emerging Biotechnologies - Stem Cell Therapy is a new report from GlobalData published on 2014-11-09. This 248-page report is available in PDF from $2995. PharmaSphere: Emerging Biotechnologies - Stem Cell Therapy Summary GlobalData’s report "PharmaSphere: Emerging Biotechnologies - Stem Cell Therapy", provides strategic analysis o...

Medical Technology Market in Europe 2014-2018

Recently added to the BioPortfolio report store, Medical Technology Market in Europe 2014-2018 is a new report from Technavio published on 2014-11-11. This 99-page report is available in pdf from $2500. About Medial Technology Medical technology refers to technology used in individuals suffering from wide range of conditions to ensure better health of the patients. It involves the entire pathwa...

Sunday 16th November 2014

Bone Therapeutics and Kasios to Collaborate on Novel Product for the Optimisation of Spinal Fusion Procedures

GOSSELIES and GILLY, Belgium and L'UNION, France, November 17, 2014 /PRNewswire/ -- Companies to develop a novel product combining Bone Therapeutics' cell therapy product ALLOB®  with Kasios's synthetic bone substitute BONE THERAPEUTICS, the regenerative therapy company addressing unmet medical needs in the fields of bone diseases and orthopaedics and KASIOS, the synthetic bone su...

First Choice Healthcare Reports Third Quarter 2014 Results

MELBOURNE, FL -- (Marketwired) -- 11/17/14 -- First Choice Healthcare Solutions, Inc. (OTCQB: FCHS) ("FCHS" or "First Choice"), a diversified holding company focused on delivering clinically superior, patient-centric, multi-specialty care through state-of-the-art medical centers of excellence, today announced its third quarter results for the three and nine months ended September 30, 2014. Finan...

OPTP Releases Updated Kaltenborn Text

MINNEAPOLIS -- First released 40 years ago, Manual Mobilization of the Joints: The Extremities, written by Freddy Kaltenborn, covered the practical foundations of joint mobilization. Now in its 8th edition, this updated and revised handbook offers an introduction to manual extremity joint evaluation and mobilization techniques with an emphasis on the application of biomechanical principles. ...

Novartis reports landmark Phase III results for AIN457 (secukinumab) showing rapid and significant efficacy in psoriatic arthritis patients

Novartis International AG / Novartis reports landmark Phase III results for AIN457 (secukinumab) showing rapid and significant efficacy in psoriatic arthritis patients . Processed and transmitted by NASDAQ OMX Corporate Solutions. The issuer is solely responsible for the content of this announcement. Secukinumab demonstrated significant and sustained efficacy versus placebo in improving signs a...

Novartis first IL-17A Phase III results show AIN457 (secukinumab) significantly improves psoriatic arthritis in patients

    EAST HANOVER, N.J., Nov. 16, 2014 /PRNewswire/ -- Novartis announced today results from the pivotal Phase III FUTURE 1 and FUTURE 2 studies showing AIN457 (secukinumab) met primary endpoints demonstrating statistically significant improvement of the signs and symptoms of psoriatic arthritis (PsA) versus placebo. PsA is part of a spectrum of long-term disease...

Saturday 15th November 2014

Novartis AIN457 (secukinumab) showed significant symptom improvement in two pivotal Phase III ankylosing spondylitis studies

EAST HANOVER, N.J., Nov. 15, 2014 /PRNewswire/ -- Novartis announced today results from the MEASURE 1 and MEASURE 2 pivotal Phase III studies of AIN457 (secukinumab) in ankylosing spondylitis (AS). In the studies, secukinumab met the primary endpoint demonstrating statistically significant improvements versus placebo in the signs and symptoms of AS. AS is a common type of spondyloarthritis (S...

Inventor and InventHelp Client Develops Improved Heating Pad (SAH-682)

InventHelp, based in Pittsburgh, is attempting to submit the Heat N Go to applicable companies for their review and possible feedback. PITTSBURGH, PA (PRWEB) November 15, 2014 "I needed a better heating pad, one that would stay in place and direct the heat exactly where I needed it," said an inventor from Lincoln, Calif. "In order to meet my needs, I developed my own heating pad.&q...

Physical Therapists Learn to Relieve a Vast Number of Pains and Dysfunctions with Fascial Manipulation

Hands-On Seminars Announces Fascial Manipulation Certification Series with World-Renowned Author and Lecturer Dr. Antonio Stecco Astoria, New York (PRWEB) November 15, 2014 Daily, family doctors, chiropractors and physical therapists around the world are challenged by patients suffering from pain, illness and dysfunction connected to problems relating to the musculoskeletal system. Correct diag...

Friday 14th November 2014

Ipsen Biopharmaceuticals, Inc. Presents Dysport® (abobotulinumtoxinA) Data at American Academy of Physical Medicine and Rehabilitation Annual Assembly

Findings Will be Presented from Largest-Ever Trial of Dysport ® in Cervical Dystonia and Phase III Trial in Upper Limb Spasticity Ipsen Biopharmaceuticals, Inc., an affiliate of Ipsen (Euronext: IPN; ADR: IPSEY), today announced multiple presentations of Dysport® data, which will be presented at the Annual Assembly of the Academy of Physical Medicine...

Premier Podiatric Surgeon from Pennsylvania, David N. Tachna, DPM, AACFAS, Receives the Honor of Publication in Worldwide Leaders in Healthcare

The International Association of HealthCare Professionals has carefully selected David N. Tachna, DPM, AACFAS, to represent podiatry in their publication, Worldwide Leaders in Healthcare.  Dr. Tachna’s selection is a significant and relevant refle...

Modernizing Medicine Debuts EMA Rheumatology at the American College of Rheumatology Annual Meeting 2014

Company Unveils Specialty-Specific, Touch-Based EMR System for Rheumatologists Modernizing Medicine, Inc., the creator of the Electronic Medical Assistant® (EMA™), a cloud-based, specialty-specific electronic medical record (EMR) system, will be debuting its

ABLYNX TO PRESENT DATA ON ITS ANTI-IL-6R NANOBODY, DEVELOPED IN PARTNERSHIP WITH ABBVIE, AT THE AMERICAN COLLEGE OF RHEUMATOLOGY ANNUAL MEETING

GHENT, Belgium, 14 November 2014 - Ablynx [Euronext Brussels: ABLX] today announced that it will present two posters on its novel anti-IL-6R Nanobody®, ALX-0061, at the 2014 American College of Rheumatology (ACR/ARHP) Annual Meeting, which is taking place from 14 to 19 November 2014 in Boston, MA, USA. The first poster presentation will include results from a post-hoc analysis of ...

Thursday 13th November 2014

Edan Highlights Acclarix AX8 Ultrasound System at American College of Rheumatology

BOSTON, MA--(Marketwired - November 14, 2014) - Edan Medical, the Silicon Valley ultrasound design center of global medical device manufacturer Edan Instruments, today announced it will introduce the Acclarix™ AX8 Compact Ultrasound System to the rheumatology market at the American College of Rheumatology annual meeting, held Nov. 16-18, 2014 at the Boston Convention and Exhibition Center.  Th...

Good Samaritan Hospital Earns 'Top Performer on Key Quality Measures®' Recognition from The Joint Commission

LOS ANGELES, Nov. 13, 2014 /PRNewswire-USNewswire/ -- Good Samaritan Hospital has been recognized as a 2013 Top Performer on Key Quality Measures® by The Joint Commission, the leading accreditor of health care organizations in the United States.  Good Samaritan Hospital was recognized as part of The Joint Commission's 2014 annual report "America's Hospitals: Improving Quality and Sa...

13 Sutter Health Hospitals Named Top Performers for Quality Health Care

SACRAMENTO, Calif., Nov. 13, 2014 /PRNewswire/ -- For the fourth year, The Joint Commission, the nation's leading accreditor of health care organizations, recognized hospitals in the Sutter Health network as among the nation's Top Performers on Key Quality Measures®. Sutter Health-affiliated hospitals have earned these quality recognitions each year since the program began in 2011. The...

Cellular Bone Matrix a Promising Step for Bone Regeneration

DePuy Synthes Companies of Johnson & Johnson, in collaboration with LifeNet Health, announced the introduction of ViviGen Cellular Bone Matrix, a differentiated cellular allograft for the repair or reconstruction of musculoskeletal defects. The a...

Cartiva Announces Completion of Multicenter Trial of Synthetic Cartilage Implant for Osteoarthritis in the Great Toe

Study is largest randomized, prospective clinical trial for osteoarthritis of the first metatarsophalangeal (MTP) joint Cartiva, Inc., a developer of innovative solutions for the treatment of cartilage damage and osteoarthritis, announced today that all scheduled two-year follow up patient visits have been completed in the MOTION study, its multicenter...

Medical Oxygen Concentrator Industry Global, Market Size 2014, Share, growth, Trends and Forecast 2019: MarketResearchReports.Biz

Global Medical Oxygen Concentrator Industry 2014 Deep Research Report provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. View Full Report at http://www.marketresearchreports.biz/analysis/230379 Albany, NY (PRWEB) November 13, 2014 The report provides Medical Oxygen Concentrator information, including its definition, classificati...


Search BioPortfolio:
Loading
Advertisement
Advertisement

News Quicklinks